Clinical trials
Terminated Phase 1 Adenocarcinoma of Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ikena Oncology | 2 |
| National Cancer Institute (NCI) | 2 |
| Imugene Limited | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Novartis Pharmaceuticals | 1 |
| Numab Therapeutics AG | 1 |
| SWOG Cancer Research Network | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenocarcinoma of Lung | 10 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.